On Our Way To EAPA

Laura Dashner CEO & President and Sandra Serrano Chief Development Officer are presenting “An Interview with Sandra Sapp: The 2018 DOT Changes Impacting Opioid Testing” at 11:15 AM on October 13th in Minneapolis.

The federal DOT regulations expanded the opioid panel to include 4 semi-synthetics on January 1, 2018.  The regulations, along with the regulatory guidance, present new challenges for employers, EAPs and SAPs. Join us for a mock interview featuring “Sandra Sapp”, sharing her expert knowledge, training, recommendations and a touch of humor to guide us through a DOT Return-to-Duty SAP process in which the employee tested positive for oxycodone.